Navigation Links
WHO States, “One Billion People Are Affected By Neurological Disorders

Neurological ailments varying from migraines to Alzheimer's disease affect almost one billion people across the world. This was reported// by WHO in ‘Neurological disorders: Public health challenges’.

The report states that 24 million people are affected by disease like Alzheimer's and other dementias and 50 million are hit by epilepsy which requires far-reaching care. These issues are compounded when there is ageing population in the developed and developing countries.

Migraine, Parkinson's disease, multiple sclerosis, strokes, and brain injuries which affect the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, and muscles are the other neurological illnesses. These ailments may result in behavioral problems, loss of memory and speech.

This report discusses the reasons for unavailable treatments for such neurological disorders. Dearth of skilled personnel, meager supply of vital drugs which includes cheap medicines like aspirin and incidence of conservative practices contribute to the higher incidence of neurological disorders especially in countries like Africa.

These disorders could be minimized if some simple precautionary procedures like immunization against meningitis, wearing of helmets and seat belt, early detection of malaria are followed stringently.
JY
'"/>




Page: 1

Related medicine news :

1. European Countries To Fund $4 Billion For Vaccination For Poor Children’
2. Generic Drugs Usage In US Can Save $20 Billion – Express Script Surve
3. UK Spends ￡7.3 Billion Annually On Malnutrition Cost
4. MP Government Allocated Rs. 3 Billion For Women-Children Nutrition
5. US $ 22 Billion Required Yearly to Fight AIDS: UN
6. NHS Billions Spent on High Cost Computer Scheme
7. Billions of Pounds Squandered on NHS
8. Billionaire’s Pet Projec
9. Once a Lawn Mower, a Self-made Billionaire Makes a Lasting Gift to Virginia Tech
10. Smokers Cost Chinese Economy Billions
11. Health Care In Canada To Cost $148 Billion In 2006: Report
Post Your Comments:
(Date:10/13/2008)...tion of low plasma levels of antioxidants and blue...rtain forms of the eye disease age-related macular...October issue of Archives of Ophthalmology , one ...s vulnerable to the damaging effects of light," th...rticle. "While wavelengths in the UV radiation ran...
(Date:10/13/2008).../ -- As the first-ever report,by the United Nation...heduled to be presented to Member States today, th...rease in the number of countries it serves.,Accord...o prevent and treat,fistula in over 45 countries i...unched in 2003, it covered 12 countries., The Sec...
(Date:10/13/2008)...rages Latinos to Get Tested, LOS ANGELES, Oct. 13...t half of all newly diagnosed HIV/AIDS cases,repor...ationally., -- A week of activities aimed at rais...esting to coincide with National Latino AIDS Aware...Our Community, Our Responsibility: Latinos in Acti...
(Date:10/13/2008)...en, study found , , MONDAY, Oct. 13 (Hea...re your brain shrinks, a new study has found. ,...ot, you,re going to hurt your brain," said Rajesh ...d experimental therapeutics at the Texas A&M H... something we knew, but this is a huge study that ...
Breaking Medicine News(10 mins):Health News:Sunlight exposure plus low antioxidant levels may place older adults at risk for eye disease 2Health News:Campaign to End Fistula Quadruples In Size, Reaching Over 45 Countries, Says New Report 2Health News:Campaign to End Fistula Quadruples In Size, Reaching Over 45 Countries, Says New Report 3Health News:Nearly Half of Newly Diagnosed HIV/AIDS Cases in Los Angeles County Are Among Latinos 2Health News:Excess Drinking Shrinks the Brain 2
...Reports say that the health providers do not treat...spect and they are not provided with correct diagn...cted in more than 1,000 men with prostate cancer a...an 22% felt they were given their diagnosis insens...
...A cloud of controversy has surrounded The Thiruvan...aiming that a one-year-old girl who had received a... tested positive for HIV infection. // According ...o is HIV-positive, was given blood, which had been...
...Shortness of breath can be a more reliable indicat... finding that such patients have a higher risk of ...diac pain or other symptoms. //The general notion ... cardiac disease has been disapproved by the findi...
...Researchers from University of Cape Town, South Af... and treat cervical cancer prevention programs in ...ow resource settings exclusively for developing an...showed that the test and treat program was very mu...
Other Medicine News:Health News:Prostate cancer patients not happy with health providers 2Health News:Shortness Of Breath A More Reliable Indicator Of High Risk Cardiac Disease 2Health News:Two screen test and treat screening for cervical cancer 2
(Date:10/13/2008)...n January 2009 and Final Trial ...t. 13 /- Neurobiological,Te...nnounced that following a,meeting with the U.S. Fo...(TM) (ancrod) Phase 3 clinical program for acute i...nd analyze data from its two concurrently,running ...
(Date:10/13/2008)... Facet Solutions, Inc. today,announced the complet...S,IDE Pilot Study. The results show a 78% reductio...n 80% reduction in Visual Analog Scores (VAS) for,... for Facet Solutions,added, "We are very pleased ...demonstrate significant pain relief but the safety...
(Date:10/12/2008)...signed for more uniform drug ..., Oct. 12 /- Boston,Scienti...rehensive data from,the TAXUS ATLAS clinical progr... single-arm, historically controlled trials, which...ng Stent System in a variety of,lesions and patien...
(Date:10/10/2008)...0 /-,XTENT, Inc. (Nasdaq: ...ng-term follow-up data from the CUSTOM I, II and I... Research Foundation,s (CRF) twentieth annual,Tran...g in Washington, DC.,The CUSTOM clinical trials ar...safety and efficacy of the Custom NX(R) drug eluti...
Breaking Medicine Technology:Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data 2Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data 3Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data 4Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 2Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 3Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 4Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 5Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 6XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week 2Eklin Medical Reports Record Revenues for 2007 3303 1Eklin Medical Reports Record Revenues for 2007 3303 2Eklin Medical Reports Record Revenues for 2007 3303 3Hayes Clinical Labs to Market MedeFiles Proprietary Electronic Medical Record Management Solution to Patients 3301 1Hayes Clinical Labs to Market MedeFiles Proprietary Electronic Medical Record Management Solution to Patients 3301 2Hayes Clinical Labs to Market MedeFiles Proprietary Electronic Medical Record Management Solution to Patients 3301 3Hayes Clinical Labs to Market MedeFiles Proprietary Electronic Medical Record Management Solution to Patients 3301 4Mylan Confirms Its Matrix Design Fentanyl Patch Is Not Included In the Widespread Recall Announced February 12th 11903 1Mylan Confirms Its Matrix Design Fentanyl Patch Is Not Included In the Widespread Recall Announced February 12th 11903 2Centene Foundation for Quality Healthcare Awards Grant to Texas Parent to Parent 11901 1Centene Foundation for Quality Healthcare Awards Grant to Texas Parent to Parent 11901 2Centene Foundation for Quality Healthcare Awards Grant to Texas Parent to Parent 11901 3
...Analysis Shows Statistically Significant Changes i...alif., March 26, 2007 /PRNewswire-FirstCall/ --,Al...e initial,results from its Phase IIa clinical tria...c patients with acute agitation. The 10 mg,dose of...rial,which was a statistically-significant reduct...
...d CAPTURE 2 Findings Suggest Improved Outcomes in ...26, 2007 /PRNewswire-FirstCall/ --,Positive 30-day...tid stenting can be performed with positive result...ience in real-world,(non-clinical trial) settings ...urgery. Interim results from the first 1,500,patie...
Other Medicine Technology:Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 2Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 3Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 4Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 5Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 6Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and,Effective Treatment to Reduce Risk of Stroke 2Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and,Effective Treatment to Reduce Risk of Stroke 3Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and,Effective Treatment to Reduce Risk of Stroke 4
BD Persist Plus protective barrier skin preps with chlorhexidine in alcohol
Triad Plus Sterile Skin Protectant Prep Pads prepares the skin for improved adhesion of a bandage or dressing. When dry, it leaves a thin film on the skin's surface. This provides a clean surface and
...opyl Alcohol 70% USP and 10% Acetone Alcoh...eptic, anti-infective prior to administering injec...al of oils and fats from the skin. They are gamma ...o contain a consistent amount of alcohol &acetone ...
Triad Plus Sterile Isopropyl Alcohol 70% USP Prep Pads are medium size. Each package is terminally sterilized, ensuring the safest possible product.
Medicine Products: